Bright Minds Biosciences (DRUG) Selling, General & Administrative (2020 - 2026)
Bright Minds Biosciences (DRUG) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 471.62 Bn | 466.83 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Bright Minds Biosciences | 699.63 Mn | 699.63 Mn | - | 545,982.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 545,982.55 |
| Dec 31, 2025 | 252,080.21 |
| Sep 30, 2025 | 192,089.60 |
| Jun 30, 2025 | 119,442.70 |
| Mar 31, 2025 | 192,806.12 |
| Dec 31, 2024 | 55,526.99 |
| Sep 30, 2024 | 35,498.11 |
| Jun 30, 2024 | 59,401.51 |
| Mar 31, 2024 | 41,532.37 |
| Dec 31, 2023 | 50,856.30 |
| Sep 30, 2023 | -34,252.38 |
| Jun 30, 2023 | 90,855.96 |
| Mar 31, 2023 | 103,552.31 |
| Dec 31, 2022 | 46,183.91 |
| Sep 30, 2022 | 78,105.37 |
| Jun 30, 2022 | 71,207.15 |
| Mar 31, 2022 | 58,374.60 |
| Dec 31, 2021 | 167,913.55 |
| Sep 30, 2021 | 72,973.64 |
| Jun 30, 2021 | 43,305.68 |